Vitro and in vivo studies have found that ginsenoside Rb1 and metabolites capable of inhibiting inflammation. Further, it is possible by reducing the IRS1 serine phosphorylation, increased activity of PI3K, promoting GLUT1, GLUT4 protein expression and Akt phosphorylation, increased glucose uptake, the role of improving the IR.
正在翻译中..